Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS & U Regulatory News (SUS)

Share Price Information for S & U (SUS)

Share Price is delayed by 15 minutes
Get Live Data
1,890.00    -25.00 (-1.31%)
Bid:
1,895.00
Ask:
1,975.00
Spread: 80.00 (4.222%)
Market Cap: £229.65m
SUS Live PriceLast checked at - London Stock Exchange

Intraday S & U Share Chart

Total Voting Rights

3 May 2016 09:13

RNS Number : 0176X
S & U PLC
03 May 2016
Β 

3 May 2016

S&U PLC

("S&U" or "the Company")

Β 

Total Voting Rights

In conformity with the Financial Conduct Authority's Disclosure and Transparency Rules provision 5.6.1, the Company hereby notifies the market of the following:

The Company's capital as at 29 April 2016 consists of 11,939,875 ordinary shares with voting rights.

The above figure may be used by shareholders as the denominator for their calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.

Β 

For further information, please contact:

S&U plcAnthony Coombs, Chairman

www.suplc.co.uk0121 705 7777

Arden Partners plcChris Hardie

020 7614 5917

SmithfieldWill Swan

020 7360 4900

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TVRUGUPGAUPQURW
Date   Source Headline
9th Apr 20217:00 amEQSEdison Investment Research Limited: S&U (SUS): Ready to meet unlocked demand
30th Mar 20217:00 amRNSPreliminary Results
18th Mar 20217:00 amRNSInvestor Presentation
11th Feb 202110:00 amRNSCORRECTION: TRADING STATEMENT & NOTICE OF RESULTS
11th Feb 20217:00 amRNSTrading Statement and Notice of Results
27th Jan 20213:40 pmRNSDirector/PDMR Shareholding
9th Dec 20204:35 pmRNSPrice Monitoring Extension
9th Dec 20207:00 amRNSTrading Statement
23rd Nov 20209:55 amRNSBlock Listing Six Monthly Return
30th Sep 20207:01 amRNSDirectorate Change
30th Sep 20207:00 amRNSInterim Results
24th Sep 20207:00 amRNSInvestor Presentation
15th Sep 20207:00 amRNSNotice of Results
28th Aug 20203:36 pmRNSHolding(s) in Company
28th Aug 20203:35 pmRNSHolding(s) in Company
11th Aug 20207:00 amRNSTRADING UPDATE AND NOTICE OF RESULTS
31st Jul 20203:06 pmRNSTotal Voting Rights
30th Jun 20205:47 pmRNSTotal Voting Rights
9th Jun 20201:10 pmRNSResult of AGM
9th Jun 20207:00 amRNSAGM Statement and Trading Update
1st Jun 202010:25 amRNSTotal Voting Rights
22nd May 20209:35 amRNSBlock Listing Six Monthly Return
13th May 202012:50 pmRNSDirector/PDMR Shareholding
6th May 20202:00 pmRNSAnnual Report and Accounts
1st May 20207:00 amRNSTotal Voting Rights
15th Apr 20204:55 pmRNSBlock Listing Application
9th Apr 20204:42 pmRNSSecond Price Monitoring Extn
9th Apr 20204:37 pmRNSPrice Monitoring Extension
8th Apr 20202:04 pmRNSPreliminary Results: Replacement
8th Apr 20207:00 amRNSPreliminary Results
6th Apr 20207:00 amRNSNotice of Results
23rd Mar 20207:00 amRNSDelay to Publication of Full Year Results
17th Mar 20204:40 pmRNSSecond Price Monitoring Extn
17th Mar 20204:36 pmRNSPrice Monitoring Extension
20th Feb 20204:41 pmRNSSecond Price Monitoring Extn
20th Feb 20204:36 pmRNSPrice Monitoring Extension
11th Feb 20207:00 amRNSTrading Statement and Notice of Results
7th Jan 20203:19 pmRNSExercise and Sale of Options, Total Voting Rights
18th Dec 20195:40 pmRNSExercise and Sale of Options, Total Voting Rights
10th Dec 20197:00 amRNSTrading Statement
2nd Dec 20192:42 pmRNSBlock listing Six Monthly Return
23rd Oct 20193:38 pmRNSExercise and Sale of Options & Total Voting Rights
22nd Oct 20192:00 pmRNSExercise and Sale of Options & Total Voting Rights
17th Oct 20194:55 pmRNSExercise of Options and Total Voting Rights
24th Sep 20197:01 amRNSAppointment by Advantage Finance of New CEO
24th Sep 20197:00 amRNSInterim Results
15th Aug 201912:08 pmRNSSecond Price Monitoring Extn
15th Aug 201912:02 pmRNSPrice Monitoring Extension
8th Aug 20197:00 amRNSTrading Update and Notice of Results
1st Aug 20197:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.